Preferred Label : Myasthenic syndrome, congenital, 4a, slow-channel;
Symbol : CMS4A;
CISMeF acronym : CMS1A1; CMS4A;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Congenital myasthenic syndrome type ia1; Cms ia1; CMS1A1;
Description : For a discussion of genetic heterogeneity of congenital myasthenic syndrome (CMS),
see 608931. See also CMS with episodic apnea (254210), which is also designated CMS
Ia. Christodoulou et al. (1997) performed linkage studies in 12 families, 7 of them
consanguineous, containing 36 patients with FIMG. A combination of linkage search
through the genome, DNA pooling, and homozygosity mapping were employed to localize
the disorder to the telomeric region of chromosome 17p. A maximum lod score of 9.28
at theta 0.034 was obtained between the disease locus and marker locus D17S1537.
Haplotype analysis showed all families to be consistent with linkage to this region,
thus providing evidence for genetic homogeneity of familial infantile myasthenia.
Multipoint linkage analysis mapped the disease gene in the interval of approximately
4 cM between marker loci D17S1537 and D17S1298 with a maximum multipoint lod score
of 12.07. Haplotype analysis and homozygosity by descent in affected individuals of
the consanguineous families revealed results in agreement with the confinement of
the FIM1 region within the interval between marker loci D17S1537 and D17S1298 on 17p13.
Synaptobrevin-2 (185881), a synaptic vesicle protein, is encoded by a gene that has
been mapped to the telomeric region of 17p, suggesting to Christodoulou et al. (1997)
that the mutation responsible for FIM1 is located in that gene. Synaptobrevin probably
participates in neurotransmitter release at a step between docking and fusion (Hunt
et al., 1994). *FIELD* RF 1. Christodoulou, K.; Tsingis, M.; Deymeer, F.; Serdaroglu,
P.; Ozdemir, C.; Al-Shehab, A.; Bairactaris, C.; Mavromatis, I.; Mylonas, I.; Evoli,
A.; Kyriallis, K.; Middleton, L. T.: Mapping of the familial infantile myasthenia
(congenital myasthenic syndrome type Ia) gene to chromosome 17p with evidence of genetic
homogeneity. Hum. Molec. Genet. 6: 635-640, 1997. 2. Hunt, J. M.; Bommert, K.; Charlton,
M. P.; Kistner, A.; Habermann, E.; Augustine, G. J.; Betz, H.: A post-docking role
for synaptobrevin in synaptic vesicle fusion. Neuron 12: 1269-1279, 1994. *FIELD*
CS Autosomal recessive;
Inheritance : Autosomal recessive (rare); Autosomal dominant;
Molecular basis : Caused by mutation in the cholinergic receptor, nicotinic, epsilon polypeptide gene
(CHRNE, 100725.0001);
Prefixed ID : #605809;
Origin ID : 605809;
UMLS CUI : C4225413;
Automatic exact mappings (from CISMeF team)
- fim 1 [MeSH Supplementary Concept]
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
Validated automatic mappings to NTBT